Income Tax Expense (Benefit) in USD of ABBOTT LABORATORIES from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
ABBOTT LABORATORIES quarterly/annual Income Tax Expense (Benefit) history and change rate from Q1 2010 to Q3 2025.
  • ABBOTT LABORATORIES Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $536M, a 82.3% increase year-over-year.
  • ABBOTT LABORATORIES Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was -$5.84B, a 678% decline year-over-year.
  • ABBOTT LABORATORIES annual Income Tax Expense (Benefit) for 2024 was -$6.39B, a 779% decline from 2023.
  • ABBOTT LABORATORIES annual Income Tax Expense (Benefit) for 2023 was $941M, a 31.5% decline from 2022.
  • ABBOTT LABORATORIES annual Income Tax Expense (Benefit) for 2022 was $1.37B, a 20.4% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

ABBOTT LABORATORIES Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$5.84B $536M +$242M +82.3% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025
Q2 2025 -$6.08B $371M +$66M +21.6% 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025
Q1 2025 -$6.15B $453M +$242M +115% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 -$6.39B -$7.2B -$7.4B -3682% 01 Oct 2024 31 Dec 2024 10-K 21 Feb 2025
Q3 2024 $1.01B $294M +$59M +25.1% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025
Q2 2024 $952M $305M +$44M +16.9% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025
Q1 2024 $908M $211M -$33M -13.5% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025
Q4 2023 $941M $201M -$86M -30% 01 Oct 2023 31 Dec 2023 10-K 21 Feb 2025
Q3 2023 $1.03B $235M -$88M -27.2% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024
Q2 2023 $1.12B $261M -$73M -21.9% 01 Apr 2023 30 Jun 2023 10-Q 31 Jul 2024
Q1 2023 $1.19B $244M -$185M -43.1% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024
Q4 2022 $1.37B $287M -$51M -15.1% 01 Oct 2022 31 Dec 2022 10-K 21 Feb 2025
Q3 2022 $1.42B $323M -$70M -17.8% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023
Q2 2022 $1.49B $334M +$175M +110% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 $1.32B $429M +$179M +71.6% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 $1.14B $338M +$108M +47% 01 Oct 2021 31 Dec 2021 10-K 16 Feb 2024
Q3 2021 $1.03B $393M +$204M +108% 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022
Q2 2021 $828M $159M +$170M 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022
Q1 2021 $658M $250M +$161M +181% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022
Q4 2020 $497M $230M +$39M +20.4% 01 Oct 2020 31 Dec 2020 10-K 17 Feb 2023
Q3 2020 $458M $189M +$46M +32.2% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021
Q2 2020 $412M -$11M -$107M -111% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 $519M $89M +$129M 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 $390M $191M -$101M -34.6% 01 Oct 2019 31 Dec 2019 10-K 18 Feb 2022
Q3 2019 $491M $143M -$23M -13.9% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020
Q2 2019 $514M $96M +$37M +62.7% 01 Apr 2019 30 Jun 2019 10-Q 29 Jul 2020
Q1 2019 $477M -$40M -$62M -282% 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020
Q4 2018 $539M $292M -$1.15B -79.7% 01 Oct 2018 31 Dec 2018 10-K 19 Feb 2021
Q3 2018 $1.69B $166M +$101M +155% 01 Jul 2018 30 Sep 2018 10-Q 31 Oct 2019
Q2 2018 $1.58B $59M +$34M +136% 01 Apr 2018 30 Jun 2018 10-Q 31 Jul 2019
Q1 2018 $1.55B $22M -$328M -93.7% 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019
Q4 2017 $1.88B $1.44B +$1.33B +1207% 01 Oct 2017 31 Dec 2017 10-K 21 Feb 2020
Q3 2017 $550M $65M -$113M -63.5% 01 Jul 2017 30 Sep 2017 10-Q 31 Oct 2018
Q2 2017 $663M $25M -$91M -78.4% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018
Q1 2017 $754M $350M +$404M 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018
Q4 2016 $350M $110M -$25M -18.5% 01 Oct 2016 31 Dec 2016 10-K 22 Feb 2019
Q3 2016 $375M $178M +$60M +50.8% 01 Jul 2016 30 Sep 2016 10-Q 02 Nov 2017
Q2 2016 $315M $116M -$84M -42% 01 Apr 2016 30 Jun 2016 10-Q 02 Aug 2017
Q1 2016 $399M -$54M -$178M -144% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017
Q4 2015 $577M $135M -$35M -20.6% 01 Oct 2015 31 Dec 2015 10-K 16 Feb 2018
Q3 2015 $612M $118M -$159M -57.4% 01 Jul 2015 30 Sep 2015 10-Q 03 Nov 2016
Q2 2015 $771M $200M -$33M -14.2% 01 Apr 2015 30 Jun 2015 10-Q 03 Aug 2016
Q1 2015 $804M $124M +$7M +5.98% 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016
Q4 2014 $797M $170M +$89M +110% 01 Oct 2014 31 Dec 2014 10-K 17 Feb 2017
Q3 2014 $708M $277M +$440M 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015
Q2 2014 $268M $233M +$108M +86.4% 01 Apr 2014 30 Jun 2014 10-Q 04 Aug 2015
Q1 2014 $160M $117M +$107M +1070% 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015
Q4 2013 $53M $81M +$661M 01 Oct 2013 31 Dec 2013 10-K 19 Feb 2016
Q3 2013 -$608M -$163M -$55.4M -51.5% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014
Q2 2013 -$553M $125M +$6.34M +5.34% 01 Apr 2013 30 Jun 2013 10-Q 05 Aug 2014
Q1 2013 -$559M $10M -$102M -91.1% 01 Jan 2013 31 Mar 2013 10-Q 07 May 2014
Q4 2012 -$457M -$580M -$555M -2206% 01 Oct 2012 31 Dec 2012 10-K 27 Feb 2015
Q3 2012 $98.1M -$108M -$306M -154% 01 Jul 2012 30 Sep 2012 10-Q 07 Nov 2013
Q2 2012 $404M $119M +$387M 01 Apr 2012 30 Jun 2012 10-Q 06 Aug 2013
Q1 2012 $17.2M $112M -$92.8M -45.3% 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013
Q4 2011 $110M -$25.2M -$352M -108% 01 Oct 2011 31 Dec 2011 10-K 21 Feb 2014
Q3 2011 $462M $198M +$25M +14.4% 01 Jul 2011 30 Sep 2011 10-Q 07 Nov 2012
Q2 2011 $437M -$268M -$535M -200% 01 Apr 2011 30 Jun 2011 10-Q 07 Aug 2012
Q1 2011 $972M $205M -$114M -35.8% 01 Jan 2011 31 Mar 2011 10-Q 08 May 2012
Q4 2010 $1.09B $327M 01 Oct 2010 31 Dec 2010 10-K 15 Feb 2013
Q3 2010 $173M 01 Jul 2010 30 Sep 2010 10-Q 04 Nov 2011
Q2 2010 $267M 01 Apr 2010 30 Jun 2010 10-Q 04 Aug 2011
Q1 2010 $319M 01 Jan 2010 31 Mar 2010 10-Q 06 May 2011

ABBOTT LABORATORIES Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$6.39B -$7.33B -779% 01 Jan 2024 31 Dec 2024 10-K 21 Feb 2025
2023 $941M -$432M -31.5% 01 Jan 2023 31 Dec 2023 10-K 21 Feb 2025
2022 $1.37B +$233M +20.4% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025
2021 $1.14B +$643M +129% 01 Jan 2021 31 Dec 2021 10-K 16 Feb 2024
2020 $497M +$107M +27.4% 01 Jan 2020 31 Dec 2020 10-K 17 Feb 2023
2019 $390M -$149M -27.6% 01 Jan 2019 31 Dec 2019 10-K 18 Feb 2022
2018 $539M -$1.34B -71.3% 01 Jan 2018 31 Dec 2018 10-K 19 Feb 2021
2017 $1.88B +$1.53B +437% 01 Jan 2017 31 Dec 2017 10-K 21 Feb 2020
2016 $350M -$227M -39.3% 01 Jan 2016 31 Dec 2016 10-K 22 Feb 2019
2015 $577M -$220M -27.6% 01 Jan 2015 31 Dec 2015 10-K 16 Feb 2018
2014 $797M +$744M +1404% 01 Jan 2014 31 Dec 2014 10-K 17 Feb 2017
2013 $53M +$510M 01 Jan 2013 31 Dec 2013 10-K 19 Feb 2016
2012 -$457M -$567M -515% 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015
2011 $110M -$977M -89.9% 01 Jan 2011 31 Dec 2011 10-K 21 Feb 2014
2010 $1.09B 01 Jan 2010 31 Dec 2010 10-K 15 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.